Explore
Validate
Learn60202-1-Ig
antibody from Proteintech Group
Targeting: PRDX2
MGC4104, NKEFB, PRP, PRX2, PRXII, TDPX1, TSA
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 60202-1-Ig - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#60202-1-Ig, RRID:AB_10918978
- Product name
- peroxiredoxin 2 antibody
- Antibody type
- Monoclonal
- Description
- KD/KO validated peroxiredoxin 2 antibody (Cat. #60202-1-Ig) is a mouse monoclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IHC, WB, ELISA.
- Reactivity
- Human, Mouse
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 3H6C4
- Vial size
- 20ul, 150ul
Submitted references Peroxiredoxins and Hypoxia-Inducible Factor-1α in Duodenal Tissue: Emerging Factors in the Pathophysiology of Pediatric Celiac Disease Patients.
PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53.
siPRDX2-elevated DNM3 inhibits the proliferation and metastasis of colon cancer cells via AKT signaling pathway.
Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway.
PRDX2 protects hepatocellular carcinoma SMMC-7721 cells from oxidative stress.
Köse FA, Pabuccuoglu A, Karakoyun M, Aydogdu S
Current issues in molecular biology 2023 Feb 20;45(2):1779-1793
Current issues in molecular biology 2023 Feb 20;45(2):1779-1793
PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53.
Wang W, Wei J, Zhang H, Zheng X, Zhou H, Luo Y, Yang J, Deng Q, Huang S, Fu Z
Cell death & disease 2021 Jun 11;12(6):605
Cell death & disease 2021 Jun 11;12(6):605
siPRDX2-elevated DNM3 inhibits the proliferation and metastasis of colon cancer cells via AKT signaling pathway.
Ma Y, Guan L, Han Y, Zhou Y, Li X, Liu Y, Zhang X, Zhang W, Li X, Wang S, Lu W
Cancer management and research 2019;11:5799-5811
Cancer management and research 2019;11:5799-5811
Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway.
Jin Y, Yang Q, Liang L, Ding L, Liang Y, Zhang D, Wu B, Yang T, Liu H, Huang T, Shen H, Tu H, Pan Y, Wei Y, Yang Y, Zhou F
Journal of experimental & clinical cancer research : CR 2018 Nov 19;37(1):277
Journal of experimental & clinical cancer research : CR 2018 Nov 19;37(1):277
PRDX2 protects hepatocellular carcinoma SMMC-7721 cells from oxidative stress.
Zhou S, Han Q, Wang R, Li X, Wang Q, Wang H, Wang J, Ma Y
Oncology letters 2016 Sep;12(3):2217-2221
Oncology letters 2016 Sep;12(3):2217-2221
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- MCF7 cells were subjected to SDS PAGE followed by western blot with 60202-1-Ig(PRDX2 antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human testis using 60202-1-Ig(PRDX2 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The peroxiredoxin 2 antibody from Proteintech is a mouse monoclonal antibody to a fusion protein of human peroxiredoxin 2. This antibody recognizes human,mouse antigen. The peroxiredoxin 2 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
